Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

46.47 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -115.554-135.893-62.091-13.827-26.811-4.67-1.319
Depreciation & Amortization 1.2250.8770.3250.3120.0960.0370.001
Deferred Income Tax 0001.6460.0150.3310
Stock Based Compensation 27.81819.8313.468.4550.8390.0180.009
Change In Working Capital 3.8440.306-0.9511.3721.4580.4850.126
Accounts Receivables -30.139-14.131-3.49-0.0730.016-0.032-0.004
Inventory -2.046-3.1073.490.073-0.0160.0320
Accounts Payables 40.33713.240.8213.883.240.2450.131
Other Working Capital -4.3084.304-1.772-2.508-1.7820.24-0.005
Other Non Cash Items -0.36-2.6130.2275.793.2650.126-0.116
Operating Cash Flow -83.027-117.493-49.033.748-21.138-3.673-1.183
Investing Activities:
Investments In Property Plant And Equipment -1.567-1.502-0.506-0.586-0.456-0.175-0.007
Acquisitions Net 00144.1230000
Purchases Of Investments -265.628-28.664-149.4380000
Sales Maturities Of Investments 73174.775.3150000
Other Investing Activites -5-4-144.1230000
Investing Cash Flow -199.195140.604-144.629-0.586-0.456-0.175-0.007
Financing Activities:
Debt Repayment 751020001.9890
Common Stock Issued 98.287118.59974.3525.49491.67357.4563.564
Common Stock Repurchased 0000-0.02800
Dividends Paid 0000000
Other Financing Activities -18.6311.577-0.3650.02140.09857.4563.564
Financing Cash Flow 154.656130.17693.9870.021131.77159.4453.564
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -127.566153.287-99.6723.183110.17755.5972.374
Cash At End Of Period 97.381224.94771.66171.332168.14957.9722.375